F-Term-List

A61K9/00-9/72;47/00-47/48

AA00
FORM

AA01

AA02

AA03

AA04

AA06

AA07

AA08

AA09

. Suppositories or bougies

. . characterised by shape or structure

. . Bougies

. . Effervescence

. Ointments

. . Hydrated ointments

. . Anhydrous ointments

. . Gels or jellies

AA11

AA12

AA13

AA14

AA16

AA17

AA18

AA19

AA20

. Solutions

. . Aqueous solutions

. . Non-aqueous solutions

. . . Oils

. Dispersants or emulsions

. . Emulsions

. . . Multiple emulsions

. . Liposomes

. . . Unilamellar structures

AA21

AA22

AA23

AA24

AA25

AA26

AA27

AA29

AA30

. . . Multiple-lamellar structures

. . Suspensions or syrups

. . . Non-aqueous substances

. . Aerosols or foams

. . . Mists

. . . Dusts

. . . Foams

. Powdered agents

. . Powder medicines

AA31

AA32

AA33

AA36

AA37

AA38

AA39

AA40

. . Granular agents or microparticles

. . Improvement of particle characteristics

. . Adsorbents

. Pills lozenges tablets troches or buccal agents

. . Direct compressed tablets

. . Sustained or slow-release preparations

. . . characterised by shape or structure

. . . . Layered or flaky types

AA41

AA42

AA43

AA44

AA45

AA46

AA47

AA48

AA49

. . . . having discrete particles in a supporting matrix

. . Coated preparations

. . . Sugar-coated tablets

. . . Coated tablets

. . . . Enteric tablets

. . Printed preparations

. . Embossed grooved or perforated preparations

. . Effervescent tablets

. . Troches or buccal agents

AA51

AA53

AA54

AA55

AA56

AA57

AA58

AA59

AA60

. Rods needles porous forms or pellets e.g. implants

. Capsule preparations

. . Hard capsules

. . . containing emulsions dispersants or liquids

. . Soft capsules

. . . Seamless capsules

. . characterised by capsule materials

. . Finishing colouring or glazing of capsules

. . Coated capsules

AA61

AA62

AA63

AA64

AA65

AA66

AA67

AA69

. . Microcapsules

. . . characterised by shape or structure

. . . . having multilayer structure

. . . Characterised by capsule materials

. . . Nanocapsules

. . . containing emulsions dispersants or liquids

. . . performing sustainable or slow release

. Chewing gum type preparations

AA71

AA72

AA73

AA74

AA75

AA76

AA77

AA78

AA79

AA80

. Cloth sheets or filamentary base materials

. . Plasters or poultices

. . . characterised by shape or structure

. . . . characterised by oily layers or adhesive layers

. . . . . characterised by crosslinking

. . . . characterised by support bodies

. . . . . Fabric or nonwoven cloth

. . . . . Plastics

. . . . . Metals

. . . . characterised by release paper

AA81

AA82

AA83

AA84

AA85

AA86

AA87

AA88

AA89

AA90

. . . . having medicine storage sections

. . . . Porous structures

. . . . Sack-type

. . . . Bifold or bag-type

. . . . having metal films

. . . containing magnetic compounds

. . . having warming or cooling means

. . Coating agents for formation of films

. . Films to be taken orally

. . . Wafers

AA93

AA94

AA95

AA96

AA97

AA98

AA99

. Medicinal preparations for smoking or inhaling

. Slow-release

. . Drug delivery systems

. . using osmotic pressure

. . . Mini-pumps

. . Flotation

. Others

BB00
SITE OF APPLICATION

BB01

BB02

BB03

BB04

BB05

BB06

BB07

. Oral application

. . Sub-lingual application

. . Throat

. . Stomach

. . Intestines

. . . Duodenum

. . . Colon

BB11

BB12

BB13

BB14

BB15

BB16

BB17

BB18

BB19

. Injection

. . Blood vessels

. . . Veins

. . . Arteries

. . Muscles

. . Subcutaneous injection

. . Instillation or transfusion agents

. . . Artificial blood plasma or artificial blood

. . . Amino acid transfusion agents

BB21

BB22

BB23

BB24

BB25

BB26

BB27

BB28

BB29

BB30

. Body cavities or mucous membranes

. . Oral cavity

. . . Periodontal mucosa or periodontal pockets

. . Eyes

. . Nasal cavities

. . Ear canals

. . Lungs

. . Urethra

. . Rectum or anus

. . Vagina or uterus

BB31

BB32

BB34

BB35

BB36

BB37

BB38

BB39

BB40

. Endermic application

. Implantations in the body

. Animals other than humans

. . Warm-blooded animals

. . . Mammals

. . . . Ruminants

. . . Birds

. . Cold-blooded animals

. Others

CC00
ACTIVE INGREDIENT OF MEDICINAL PREPARATION

CC01

CC03

CC04

CC05

CC06

CC07

CC09

CC10

. Nervous systems

. Biological-protection mechanisms

. . Anti-inflammatory agents

. . . Non-steroid agents

. . Vaccines

. . Immuno-activating or regulating agents

. Effects on individual organs

. . Sensory organs eyes ears or nose

CC11

CC12

CC13

CC14

CC15

CC16

CC17

CC18

CC19

CC20

. . Circulatory system organs

. . . Beta blockers

. . . Angina pectoris

. . Hematopoietic organs blood or body fluids

. . Respiratory organs

. . Digestive organs

. . Urinary organs or reproductive organs

. . Outer skin

. . . Wounds or burns

. . . Athlete's foot or psoriasis

CC21

CC22

CC23

CC24

CC26

CC27

CC29

CC30

. Metabolic systems

. . Vitamins

. . . Fat-soluble vitamins

. . . Water-soluble vitamins

. Effects on tissue cell functions

. . Anticancer agents

. Substances that activate physiological compounds in living bodies

. . Hormone analogues

CC31

CC32

CC33

CC34

CC35

CC37

CC38

CC40

. Effects on pathogenic organisms

. . Antibiotics

. . . Beta-lactams

. . Anti-parasitic agents

. . Antiviral agents

. Agents for physical treatment

. . Agents for moxibustion

. Functional foods

CC41

CC42

CC43

CC44

CC45

CC46

CC47

CC50

. Active ingredients modified chemically or physicochemically

. . Prodrugs

. . Hydrated substances

. . Salts

. . . Metal salts

. . . Organic acid salts

. . Inclusion

. Others

DD00
INERT INGREDIENT 1

DD01

DD02

DD03

DD04

DD05

DD06

DD07

DD08

DD09

DD10

. Surfactants

. . Anionic surfactants

. . . Carboxylic acids

. . . Sulfonates

. . . Sulfates

. . . Phosphoric acids

. . Non-ionic surfactants

. . . containing hydroxy group e.g. polyhydric alcohol esters

. . . Polyalkylene oxides

. . . . Alkanolamides

DD12

DD13

DD14

DD15

DD16

DD17

DD18

DD19

. . Amphoteric surfactants

. . . Carboxylic acids and ammonium ions e.g. betaine

. . . Sulfonic acid sulfuric acid and ammonium ions

. . . Phosphoric acids and ammonium ions

. . Cationic surfactants

. . . Amines

. . . Nitrogen containing heterocyclic rings

. . . Quaternary ammonium compounds

DD21

DD22

DD23

DD24

DD25

DD26

DD27

DD28

DD29

DD30

. Inorganic compounds

. . Inorganic acids or inorganic acid salts

. . . Halogenated hydrogen acid salts

. . . Sulfates or sulfites

. . . Carbonates or hydrogen carbonates

. . . Phosphates or polyphosphates

. . . Silicates

. . . . Clay minerals

. . Oxides

. . Hydroxides

DD31

DD33

DD34

DD35

DD36

DD37

DD38

DD39

DD40

. . Ammonia or ammonium ions

. Organic compounds

. . Hydrocarbons

. . Halogenated hydrocarbons

. . Oxygen-containing hydrocarbons

. . . Alcohols or phenols

. . . . Polyhydric alcohol

. . . Ethers

. . . Ketones or aldehydes

DD41

DD42

DD43

DD44

DD45

DD46

DD47

DD48

DD49

DD50

. . . Carboxylic acids or salts or acid anhydrides thereof

. . . . Polycarboxylic acids

. . . . Oxycarboxylic acids

. . . Esters

. . . . Monocarboxylic acid esters

. . . . . Polyhydric alcohol esters

. . . . Polycarboxylic acid esters

. . Nitrogen-containing hydrocarbons

. . . Amines

. . . . Alkanolamines

DD51

DD52

DD53

DD54

DD55

DD56

DD57

DD58

DD59

DD60

. . . . Aminocarboxylic acids

. . . Amides

. . . Carbamic acids

. . . Ureas

. . Sulfur-containing hydrocarbons

. . . Mercaptans

. . . Sulfonic acids

. . Heterocyclic compounds

. . . containing oxygen as hetero atom

. . . containing nitrogen as hetero atom

DD61

DD62

DD63

DD64

DD65

DD66

DD67

DD68

DD69

DD70

. . . containing sulfur as hetero atom

. . Compounds containing elements other than carbon hydrogen halogens oxygen nitrogen or sulfur

. . . containing phosphorus

. . . containing silicon

. . . containing metals e.g. chelates

. . Carbohydrates

. . . Saccharide groups only

. . . Sugar esters

. . . Glycosides

. . Steroids

DD80

. Others

EE00
INERT INGREDIENT 2

EE01

EE02

EE03

EE04

EE05

EE06

EE07

EE08

EE09

EE10

. Macromolecules

. . obtained by reactions involving only carbon-to-carbon double bonds

. . . Carbon or hydrogen only

. . . . Diene rubbers

. . . Carbon hydrogen or halogen only

. . . terminated by alcohol groups e.g. polyvinyl alcohol (PVA) or polyvinylbutyral (PVB)

. . . terminated by acyloxy groups e.g. vinyl acetate

. . . Unsaturated monocarboxylic acids

. . . . Acrylic acids

. . . . . Esters

EE11

EE12

EE13

EE14

EE15

EE16

EE17

EE18

EE19

EE20

. . . . Methyacrylic acids

. . . . . Esters

. . . . containing nitrogen e.g. acrylonitriles

. . . . containing sulfur

. . . Unsaturated polyhydric carboxylic acid maleic acid or fumaric acid

. . . containing heterocyclic compounds e.g. polyvinylpyrrolidone (PVP)

. . obtained by reactions other than involving only carbon-to-carbon double bonds

. . . Aldehydes or ketones

. . . . Addition polymers or polyacetals

. . . . Condensation polymers

EE21

EE22

EE23

EE24

EE25

EE26

EE27

EE30

. . . Isocyanates

. . . . Polyurethanes

. . . Polyethers or polythioethers e.g. polyethylene glycol (PEG)

. . . Polyesters

. . . . containing nitrogen

. . . Polyamides

. . . containing silicon e.g. polysiloxane

. . Polysaccharides

EE31

EE32

EE33

EE36

EE37

EE38

EE39

. . . Cellulose

. . . . Cellulose ethers

. . . . Cellulose esters

. . . Alginic acid

. . . Chitin chondroitin sulfate or hyaluronic acid

. . . Starches

. . . Cyclodextrin

EE41

EE42

EE43

EE45

EE46

EE47

EE48

EE49

EE50

. . Proteins or polypeptides

. . . Gelatin

. . . Collagen

. . Crosslinked substances

. . . produced with the use of energy beams

. . . produced with the use of crosslinking agents

. . Copolymers

. . . Block copolymers

. . . Graft copolymers

EE51

EE52

EE53

EE54

EE55

EE56

EE57

EE58

EE59

EE60

. Oils fats or waxes

. . Oily raw materials

. . . Vegetable oils

. . . Animal oils

. . Waxes

. Ingredients of undetermined constitution or reaction products therefrom

. . of animal origin

. . of vegetable origin

. Inert ingredients chemically-bound to active ingredients

. Others

FF00
PURPOSE OR FUNCTION

FF01

FF02

FF03

FF04

FF05

FF06

FF07

FF09

. Solid preparations

. . Carriers

. . . with absorption adsorption or impregnation properties

. . Excipients

. . Bonding agents

. . Disintegrating agents elution promoters or swelling agents

. . Solidification or sticking inhibitors

. . Smoothing and brightening agents

FF11

FF12

FF13

FF14

FF15

FF16

FF17

FF18

. Liquid preparations

. . Solvents or solutions

. . Extenders

. . Isotonic agents

. . Auxiliary dissolving or solubilising agents

. . Emulsifiers suspension agents or dispersants

. . Viscosity regulators or thickeners

. . Container adsorption inhibitors

FF21

FF22

FF23

FF24

FF25

FF26

FF27

FF28

FF29

. Coating agents

. . insoluble in water

. . Water-soluble agents

. . . soluble in the stomach

. . . soluble in the intestines

. . for sugar coating

. . for outer layers

. . for inner layers

. . Auxiliary agents for formation of coating

FF31

FF32

FF33

FF34

FF35

FF36

FF37

FF39

. Slow or sustainable release

. . Biologically absorbed substances

. Quick release or quick-dissolving preparations

. Absorption accelerators or penetrants

. Gelling agents or coagulation accelerators

. Preparation stabilisers

. . Light stabilisers

. . Preservatives or antiseptics

FF41

FF43

FF46

. . Moisture-proofing agents

. . Emulsion suspension or dispersion stabilisers

. . Colouring inhibitors

FF51

FF52

FF53

FF54

FF55

FF56

FF57

FF60

. . Deoxygenators or anti-oxidants

. Taste-enhancing or odour-enhancing agents

. Colouring agents pigments paints or bleaching agents

. Foaming agents

. Defoaming agents

. Anesthetising agents e.g. for preventing cutaneous stimulation

. Moisturizers or humectants

. Charging inhibitors

FF61

FF63

FF64

FF65

FF66

FF67

FF68

FF70

. Buffering agents or pH regulators

. Primary medication stabilisers

. . Prevention of isomerisation

. . Prevention of decomposition

. Interaction inhibitors

. Agents for reduction of side-effects

. Methods or paths for dosing

. Others

GG00
PROCESS FOR PREPARATION

GG01

GG02

GG03

GG04

GG05

GG06

GG07

GG08

GG09

GG10

. Processes for solid preparations

. . Methods of powdering

. . . Pulverisation

. . . Sorting or sieving

. . . Drying

. . . . Freeze-drying

. . . . . Freeze-drying from aqueous solutions

. . . . . Freeze-drying from suspensions or emulsions

. . . . Spray-drying

. . . . Granulation of oils and fats or liquid substances

GG11

GG12

GG13

GG14

GG16

GG17

GG18

. . Formation methods

. . . Granulation

. . . . Use of fluidised beds

. . . Tablet production

. . Methods of coating

. . . Use of fluidised beds

. . . Powder coating

GG21

GG22

GG23

GG24

GG25

GG26

GG27

GG28

GG29

GG30

. . . Microcapsulation

. . . . accompanied by chemical reactions

. . . . . accompanied by polymerisation reactions

. . . . . . Interfacial polymerisation

. . . . . . Methods for hardening in liquids

. . . . accompanied by physical and chemical methods

. . . . . Coacervation methods

. . . . . . Simple coacervation methods

. . . . . . Complex corecervation methods

. . . . . Interface precipitation i.e. drying in liquids

GG31

GG32

GG33

GG36

GG37

. . . . Physical methods

. . . . . Spray drying

. . . . . Fluid coating

. . Post-treatment

. . . Capsule sealing

GG41

GG42

GG43

GG44

GG45

GG46

GG47

GG50

. Processes for liquid preparations

. . Refining separating or washing

. . . Sterilisation or removal of pyrogens

. . . Water treatment

. . Stabilisation

. . Solubilisation

. . Production of solid preparations that dissolve when in use

. Others

4C076	MEDICINAL PREPARATION
	A61K9/00 -9/72;47/00-47/69